- All sections
- C - Chemistrymetallurgy
- C12N - Microorganisms or enzymescompositions thereofpropagating, preserving, or maintaining microorganismsmutation or genetic engineeringculture media
- C12N 15/08 - Cells resulting from interspecies fusion
Patent holdings for IPC class C12N 15/08
Total number of patents in this class: 30
10-year publication summary
|
0
|
0
|
3
|
2
|
1
|
0
|
1
|
1
|
1
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Adverum Biotechnologies, Inc. | 94 |
2 |
| Cellscript, LLC. | 19 |
2 |
| Cytomatrix Pty Ltd | 6 |
2 |
| Lankenau Institute for Medical Research | 94 |
2 |
| University of Washington | 2312 |
2 |
| Novartis AG | 10927 |
1 |
| Massachusetts Institute of Technology | 10002 |
1 |
| Life Technologies Corporation | 3265 |
1 |
| President and Fellows of Harvard College | 5942 |
1 |
| Novozymes, Inc. | 287 |
1 |
| Eppendorf AG | 152 |
1 |
| Kyoto University | 2790 |
1 |
| National University Corporation Okayama University | 475 |
1 |
| Ngee Ann Polytechnic | 49 |
1 |
| The Ohio State University Research Foundation | 533 |
1 |
| OncoSec Medical Incorporated | 23 |
1 |
| Sakata Seed Corporation | 309 |
1 |
| Sowakai Medical Foundation | 13 |
1 |
| The University of Tokyo | 4146 |
1 |
| Zhejiang University | 3087 |
1 |
| Other owners | 5 |